首页> 美国卫生研究院文献>In Silico Pharmacology >Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor
【2h】

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor

机译:模拟和比较分析A2B腺苷受体上核苷和非核苷激动剂的结合方式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeA2B receptor agonists are studied as possible therapeutic tools for a variety of pathological conditions. Unfortunately, medicinal chemistry efforts have led to the development of a limited number of potent agonists of this receptor, in most cases with a low or no selectivity versus the other adenosine receptor subtypes. Among the developed molecules, two structural families of compounds have been identified based on nucleoside and non-nucleoside (pyridine) scaffolds. The aim of this work is to analyse the binding mode of these molecules at 3D models of the human A2B receptor to identify possible common interaction features and the key receptor residues involved in ligand interaction.
机译:目的研究A2B受体激动剂作为各种病理状况的可能治疗工具。不幸的是,药物化学的努力已经导致开发了这种受体的有限数量的有效激动剂,在大多数情况下,与其他腺苷受体亚型相比选择性低或没有。在已开发的分子中,已基于核苷和非核苷(吡啶)支架鉴定出化合物的两个结构家族。这项工作的目的是在人类A2B受体的3D模型上分析这些分子的结合模式,以识别可能的共同相互作用特征和参与配体相互作用的关键受体残基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号